These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 18847323

  • 1. Combination treatment with a selective androgen receptor modulator q(SARM) and a bisphosphonate has additive effects in osteopenic female rats.
    Vajda EG, Hogue A, Griffiths KN, Chang WY, Burnett K, Chen Y, Marschke K, Mais DE, Pedram B, Shen Y, van Oeveren A, Zhi L, López FJ, Meglasson MD.
    J Bone Miner Res; 2009 Feb; 24(2):231-40. PubMed ID: 18847323
    [Abstract] [Full Text] [Related]

  • 2. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A, Tanaka M, Nozaki K, Mori M, Fukushima S, Mori H, Shiroya T, Nakamura T.
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics and pharmacodynamics of LGD-3303 [9-chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3H-pyrrolo-[3,2-f]quinolin-7(6H)-one], an orally available nonsteroidal-selective androgen receptor modulator.
    Vajda EG, López FJ, Rix P, Hill R, Chen Y, Lee KJ, O'Brien Z, Chang WY, Meglasson MD, Lee YH.
    J Pharmacol Exp Ther; 2009 Feb; 328(2):663-70. PubMed ID: 19017848
    [Abstract] [Full Text] [Related]

  • 4. Odanacatib Restores Trabecular Bone of Skeletally Mature Female Rabbits With Osteopenia but Induces Brittleness of Cortical Bone: A Comparative Study of the Investigational Drug With PTH, Estrogen, and Alendronate.
    Khan MP, Singh AK, Singh AK, Shrivastava P, Tiwari MC, Nagar GK, Bora HK, Parameswaran V, Sanyal S, Bellare JR, Chattopadhyay N.
    J Bone Miner Res; 2016 Mar; 31(3):615-29. PubMed ID: 26391310
    [Abstract] [Full Text] [Related]

  • 5. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
    Iwaniec UT, Mosekilde L, Mitova-Caneva NG, Thomsen JS, Wronski TJ.
    Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological characterization of an imidazolopyrazole as novel selective androgen receptor modulator.
    Zhang X, Allan GF, Tannenbaum P, Sbriscia T, Linton O, Lai MT, Haynes-Johnson D, Bhattacharjee S, Lundeen SG, Sui Z.
    J Steroid Biochem Mol Biol; 2013 Mar; 134():51-8. PubMed ID: 23098693
    [Abstract] [Full Text] [Related]

  • 7. Odanacatib, effects of 16-month treatment and discontinuation of therapy on bone mass, turnover and strength in the ovariectomized rabbit model of osteopenia.
    Duong LT, Crawford R, Scott K, Winkelmann CT, Wu G, Szczerba P, Gentile MA.
    Bone; 2016 Dec; 93():86-96. PubMed ID: 27639811
    [Abstract] [Full Text] [Related]

  • 8. A comparative study of the bone metabolic response to dried plum supplementation and PTH treatment in adult, osteopenic ovariectomized rat.
    Smith BJ, Bu SY, Wang Y, Rendina E, Lim YF, Marlow D, Clarke SL, Cullen DM, Lucas EA.
    Bone; 2014 Jan; 58():151-9. PubMed ID: 24125756
    [Abstract] [Full Text] [Related]

  • 9. OPG and PTH-(1-34) have additive effects on bone density and mechanical strength in osteopenic ovariectomized rats.
    Kostenuik PJ, Capparelli C, Morony S, Adamu S, Shimamoto G, Shen V, Lacey DL, Dunstan CR.
    Endocrinology; 2001 Oct; 142(10):4295-304. PubMed ID: 11564687
    [Abstract] [Full Text] [Related]

  • 10. Pharmacodynamic responses to combined treatment regimens with the calcium sensing receptor antagonist JTT-305/MK-5442 and alendronate in osteopenic ovariectomized rats.
    Fisher JE, Scott K, Wei N, Zhao JZ, Cusick T, Tijerina M, Karanam B, Duong L, Glantschnig H.
    Bone; 2012 Jun; 50(6):1332-42. PubMed ID: 22445539
    [Abstract] [Full Text] [Related]

  • 11. Selective Androgen Receptor Modulator (SARM) treatment prevents bone loss and reduces body fat in ovariectomized rats.
    Kearbey JD, Gao W, Narayanan R, Fisher SJ, Wu D, Miller DD, Dalton JT.
    Pharm Res; 2007 Feb; 24(2):328-35. PubMed ID: 17063395
    [Abstract] [Full Text] [Related]

  • 12. Treatment with the combination of ibandronate plus eldecalcitol has a synergistic effect on inhibition of bone resorption without suppressing bone formation in ovariectomized rats.
    Sakai S, Takeda S, Sugimoto M, Shimizu M, Shimonaka Y, Yogo K, Hashimoto J, Bauss F, Endo K.
    Bone; 2015 Dec; 81():449-458. PubMed ID: 26281770
    [Abstract] [Full Text] [Related]

  • 13. The new selective estrogen receptor modulator MDL 103,323 increases bone mineral density and bone strength in adult ovariectomized rats.
    Ammann P, Bourrin S, Bonjour JP, Brunner F, Meyer JM, Rizzoli R.
    Osteoporos Int; 1999 Dec; 10(5):369-76. PubMed ID: 10591834
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A selective androgen receptor modulator with minimal prostate hypertrophic activity restores lean body mass in aged orchidectomized male rats.
    Allan G, Sbriscia T, Linton O, Lai MT, Haynes-Johnson D, Bhattacharjee S, Ng R, Sui Z, Lundeen S.
    J Steroid Biochem Mol Biol; 2008 Jun; 110(3-5):207-13. PubMed ID: 18502117
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of ostarine as a selective androgen receptor modulator in a rat model of postmenopausal osteoporosis.
    Hoffmann DB, Komrakova M, Pflug S, von Oertzen M, Saul D, Weiser L, Walde TA, Wassmann M, Schilling AF, Lehmann W, Sehmisch S.
    J Bone Miner Metab; 2019 Mar; 37(2):243-255. PubMed ID: 29785666
    [Abstract] [Full Text] [Related]

  • 17. Combination therapy with eldecalcitol and alendronate has therapeutic advantages over monotherapy by improving bone strength.
    Sakai S, Endo K, Takeda S, Mihara M, Shiraishi A.
    Bone; 2012 May; 50(5):1054-63. PubMed ID: 22366400
    [Abstract] [Full Text] [Related]

  • 18. A comparative study of the bone-restorative efficacy of anabolic agents in aged ovariectomized rats.
    Iwaniec UT, Moore K, Rivera MF, Myers SE, Vanegas SM, Wronski TJ.
    Osteoporos Int; 2007 Mar; 18(3):351-62. PubMed ID: 17120182
    [Abstract] [Full Text] [Related]

  • 19. Effects of glucocorticoid on BMD, micro-architecture and biomechanics of cancellous and cortical bone mass in OVX rabbits.
    Liu X, Lei W, Wu Z, Cui Y, Han B, Fu S, Jiang C.
    Med Eng Phys; 2012 Jan; 34(1):2-8. PubMed ID: 21775186
    [Abstract] [Full Text] [Related]

  • 20. Effects of 4-amino-1-hydroxybutylidene bisphosphonate on bone biomechanics in rats.
    Toolan BC, Shea M, Myers ER, Borchers RE, Seedor JG, Quartuccio H, Rodan G, Hayes WC.
    J Bone Miner Res; 1992 Dec; 7(12):1399-406. PubMed ID: 1481726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.